Luvox and Cablivi drug interactions - a phase IV clinical study of FDA data
Summary:
We study 14,586 people who take Luvox (fluvoxamine maleate) and Cablivi (caplacizumab-yhdp). There is no drug interaction reported.
The study analyzes what interactions people have when they take Luvox and Cablivi. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
What is Luvox?
Luvox has active ingredients of fluvoxamine maleate. It is often used in obsessive-compulsive disorder. eHealthMe is studying from 13,439 Luvox users. Check the latest studies of Luvox.
What is Cablivi?
Cablivi has active ingredients of caplacizumab-yhdp. eHealthMe is studying from 1,147 Cablivi users. Check the latest studies of Cablivi.
No report is found.
Do you take Luvox and Cablivi?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Related publications that referenced our studies
- Pang, T., & Gudi, A., "Chest pain following the use of fluvoxamine in depression", Proceedings of Singapore Healthcare, 2018 Jan .
- Pang, T., & Gudi, A., "Chest pain following the use of fluvoxamine in depression", Proceedings of Singapore Healthcare, 2018 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on fluvoxamine maleate and caplacizumab-yhdp (the active ingredients of Luvox and Cablivi, respectively), and Luvox and Cablivi (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Hypothyroidism in Profen, how severe and when it was recovered? - now
- Clonidine and Hallucinogen Abuse for Men aged 20-29 - now
- Clonidine and Cocaine Abuse for Men aged 20-29 - now
- Clonidine and Substance Abuse for Men aged 20-29 - a second ago
- Could Ginkgo Biloba cause Ocular Hyperaemia? - 3 seconds ago
- Syndopa vs. Aricept, side effect and effectiveness comparison - 5 seconds ago
- Could Eszopiclone cause Eye Irritation? - 5 seconds ago
- Drug interactions of Xopenex and Cholestyramine - 8 seconds ago
- Citalopram Hydrobromide and Myoclonus for Women aged 40-49 - 10 seconds ago
- Could Vivitrol cause Cyst? - 12 seconds ago